Trials / Unknown
UnknownNCT05125770
Study on the Fetal Safety of New Coronavirus Vaccination for Couples During the Peri-pregnancy Period
Study on the Safety of New Coronavirus Vaccination for Couples During the Peri-pregnancy Period on the Fetus
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Beijing Ditan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
All the pregnant women and newborns of both or one of the couples who gave birth in Ditan hospital were collected as the observation group, and the pregnant women and newborns of both husband and wife who gave birth in our hospital without new crown vaccine during pregnancy were collected as the control group. The incidence of adverse events during pregnancy of the two groups and the incidence of intrauterine development and congenital malformations of the two groups were observed to observe the physical and intellectual development of children in the two groups at the age of 1 year, and to explore the safety of perinatal neocrown vaccination.
Detailed description
This study is a prospective observational cohort study. All the pregnant women and newborns of both or one of the couples who gave birth in Ditan hospital were collected as the observation group, and the pregnant women and newborns of both husband and wife who gave birth in our hospital without new crown vaccine during pregnancy were collected as the control group. The incidence of adverse events during pregnancy of the two groups and the incidence of intrauterine development and congenital malformations of the two groups were observed to observe the physical and intellectual development of children in the two groups at the age of 1 year, and to explore the safety of perinatal neocrown vaccination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | New crown vaccine | New Coronavirus vaccine |
Timeline
- Start date
- 2021-11-08
- Primary completion
- 2024-12-30
- Completion
- 2024-12-30
- First posted
- 2021-11-18
- Last updated
- 2021-11-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05125770. Inclusion in this directory is not an endorsement.